Tylent Technologies was established in 2024 to challenge the status quo.
We are working to restart the i.v. compounding automation industry, which has been stalling for over 25 years due to legacy architecture failures with less than 1% market acceptance in Europe.
Our purpose is to empower Hospitals and Compounding Centre pharmacies with a new global standard for I.V. medication compounding: one where safety, speed, and absolute precision are no longer compromised by outdated design, but ensured through a scalable platform built to make life-saving treatments safer and more accessible for everyone.
Tylent Technologies is part of GPI Group, a leading international provider of Healthcare ICT listed on Euronext Milan.
GPI brings decades of experience in digital health, hospital systems and healthcare automation, with operations across multiple countries. Its industrial strength, financial solidity and long-term outlook provide Tylent Technologies with a stable platform for sustained growth.

Tylent Technologies Srl

Org chart

Teams

Offices